15 Years of IGB: Developing new drugs to battle cancer
In honor of the IGB's anniversary, we're revisiting some of the history of our institute over the past 15 years with a series of articles highlighting IGB people, projects, and research.
In honor of the IGB's anniversary, we're revisiting some of the history of our institute over the past 15 years with a series of articles highlighting IGB people, projects, and research.
Oxidants found within living organisms are byproducts of metabolism and are essential to wound-healing and immunity. However, when their concentrations become too high, inflammation and tissue damage can occur. University of Illinois engineers have developed and tested a new drug-delivery system that senses high oxidant levels and responds by administering just the right amount of antioxidant to restore this delicate balance.
The findings are published in the journal Small.
Bacteria are master engineers of small, biologically useful molecules. A new study in Nature Communications (DOI: 10.1038/s41467-018-06083-7) has revealed one of the tricks of this microbial trade: synthesizing and then later inserting a nitrogen-nitrogen bond, like a prefabricated part, into a larger molecule.
Illinois researchers develop a database that will guide and streamline the search for naturally produced antibiotics